Neurocrine Biosciences Inc SEC filings NBIX
Neurocrine Biosciences Inc has 1,001 filings in SEC EDGAR's recent list, going back to Feb 8, 2018. Its latest annual report, Form ARS, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 2, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SC TO-T/A | Filing | May 18, 2026 | — |
| SC TO-T/A | Filing | Apr 29, 2026 | — |
| SC TO-T/A | Filing | Apr 28, 2026 | — |
| SC TO-T | Filing | Apr 20, 2026 | — |
| SC TO-C | Filing | Apr 7, 2026 | — |
| SC TO-C | Filing | Apr 6, 2026 | — |
| SC TO-C | Filing | Apr 6, 2026 | — |
| CT ORDER | Filing | Jan 18, 2022 | — |
| CT ORDER | Filing | Dec 30, 2021 | — |
| UPLOAD | Letter from the SEC | Nov 15, 2021 | — |
| CORRESP | Letter to the SEC | Nov 3, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 27, 2021 | — |
| CORRESP | Letter to the SEC | Oct 5, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 22, 2021 | — |
| CT ORDER | Filing | Sep 27, 2019 | — |
| CT ORDER | Filing | Mar 19, 2019 | — |
| CT ORDER | Filing | Jun 5, 2018 | — |
| CT ORDER | Filing | May 8, 2018 | — |
| CT ORDER | Filing | Feb 16, 2018 | — |
Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- NBIX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 914475
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.